Decreased brain levels of vitamin B12 in aging, autism and schizophrenia

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Zhang, Yiting ^a   Hodgson, Nathaniel W ^a,b   Trivedi, Malav S ^a,c   Abdolmaleky, Hamid M ^d   Fournier, Margot ^e   Cuenod, Michel ^e   Do, Kim Quang ^e   Deth, Richard C ^a,c  

^a NORTHEASTERN UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NOVA SOUTHEASTERN UNIVERSITY   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CYANOCOBALAMIN; GCLM PROTEIN, MOUSE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; MECOBALAMIN;

ADOLESCENT; ADULT; AGED; AGING; ANALOGS AND DERIVATIVES; ANIMAL; AUTISM; C57BL MOUSE; CHILD; DNA METHYLATION; FRONTAL LOBE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INFANT; KNOCKOUT MOUSE; METABOLISM; MIDDLE AGED; MOUSE; NEWBORN; PRESCHOOL CHILD; SCHIZOPHRENIA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; ANIMALS; ANTIOXIDANTS; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; DNA METHYLATION; FRONTAL LOBE; GENE EXPRESSION REGULATION; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; HUMANS; INFANT; INFANT, NEWBORN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; SCHIZOPHRENIA; VITAMIN B 12; YOUNG ADULT;

EID: 84958205925     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0146797     Document Type: Article

References (91)

1. Guéant JL, Caillerez-Fofou M, Battaglia-Hsu S, Alberto JM, Freund JN, Dulluc I et al. Molecular and cellular effects of vitamin B12 in brain, myocardium and liverthrough its role as co-factor of methionine synthase. Biochimie. 2013;95:1033-1040. doi: 10.1016/j.biochi.2013.01.020 PMID: 23415654
2. Gherasim C, Lofgren M, Banerjee R. Navigating the B (12) road: assimilation, delivery, and disorders of cobalamin. J Biol Chem. 2013;288:13186-13193. doi: 10.1074/jbc. R113.458810 PMID: 23539619
3. Park LK, Friso S, Choi SW. Nutritional influences on epigenetics and age-related disease. Proc Nutr Soc. 2012;71:75-83. doi: 10.1017/S0029665111003302 PMID: 22051144
4. Sharma A, Kramer ML, Wick PF, Liu D, Chari S, Shim S. et al. D4 dopamine receptor-mediated phospholipid methylation and its implications for mental illnesses such as schizophrenia. Mol Psychiatry. 1999;4:235-246. PMID: 10395213
5. Waly M, Olteanu H, Banerjee R, Choi SW, Mason JB, Parker BS, et al. Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal. Mol Psychiatry. 2004;9:358-370. PMID: 14745455
6. Kuznetsova AY, Deth RC. A model for modulation of neuronal synchronization by D4 dopamine receptor-mediated phospholipid methylation. J Comput Neurosci. 2008;24:314-329. PMID: 17929154
7. Swanson JM, Kinsbourne M, Nigg J, Lanphear B, Stefanatos GA, Volkow N et al. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol Rev. 2007;17:39-59. PMID: 17318414
8. Tarazi FI, Baldessarini RJ. Dopamine D4 receptors: significance for molecular psychiatry at the millennium. Mol Psychiatry 1999;4:529-538. PMID: 10578234
9. Lai JH, Zhu YS, Huo ZH, Sun RF, Yu B, Wang YP, et al. Association study of polymorphisms in the promoter region of DRD4 with schizophrenia, depression, and heroin addiction. Brain Res 2010;1359:227-232. doi: 10.1016/j.brainres.2010.08.064 PMID: 20801104
10. Cheng J, Wang Y, Zhou K, Wang L, Li J, Zhuang Q, et al. Male-specific association between dopamine receptor D4 gene methylation and schizophrenia. PLoS One. 2014;9:e89128. doi: 10.1371/journal. pone.0089128 PMID: 24586542
11. Grady DL, Thanos PK, Corrada MM, Barnett JC Jr, Ciobanu V, Shustarovich D. et al. DRD4genotype predicts longevity in mouse and human. J Neurosci. 2013;33:286-291. doi: 10.1523/JNEUROSCI. 3515-12.2013 PMID: 23283341
12. Gille D, Schmid A. Vitamin B12in meat and dairy products. Nutr Rev. 2015;73:106-115. doi: 10.1093/nutrit/nuu011 PMID: 26024497
13. Kozyraki R, Cases O. Vitamin B12 absorption: mammalian physiology and acquired and inherited disorders. Biochimie. 2013;95:1002-1007. doi: 10.1016/j.biochi.2012.11.004 PMID: 23178706
14. Carro E, Spuch C, Trejo JL, Antequera D, Torres-Aleman I. Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor I. J Neurosci. 2005;25:10884-10893. PMID: 16306401
15. Christensen EI, Birn H. Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol 2002;3:256-266. PMID: 11994745
16. Luder AS, Tanner SM, dela Chapelle A, Walter JH. Amnionless (AMN) mutations in Imerslund-Gräsbeck syndrome may be associated with disturbed vitamin B (12) transport into the CNS. J Inherit Metab Dis. 2008;31 Suppl 3:493-6. doi: 10.1007/s10545-007-0760-2 PMID: 18181028
17. Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013;368:149-160. doi: 10.1056/NEJMcp1113996 PMID: 23301732
18. Kirsch SH, Herrmann W, Obeid R. Genetic defects in folate and cobalamin pathways affecting the brain. Clin Chem Lab Med. 2013;51:139-155. doi: 10.1515/cclm-2012-0673 PMID: 23183749
19. Worm-Peterson J. Vitamin B12 haemoglobin and iron concentration in human brain tissue. Acta Neurol Scand. 1964;40:241-8. PMID: 14192302
20. Baker H, Frank O, Chen T, Feingold S, De Angelis B, Baker E. Vitamin content of some normal human brain segments. J Neurosci Res. 1984;11:419-35. PMID: 6235380
21. Numata S, Ye T, Hyde TM, Guitart-Navarro X, Tao R, Wininger M. et al. DNA methylation signatures in development and aging of the human prefrontal cortex. Am J Hum Genet. 2012;90:260-272. doi: 10. 1016/j.ajhg.2011.12.020 PMID: 22305529
22. Gapp K, Woldemichael BT, Bohacek J, Mansuy IM. Epigenetic regulation in neurodevelopmentand neurodegenerative diseases. Neuroscience. 2014;264:99-111. doi: 10.1016/j.neuroscience.2012.11. 040 PMID: 23256926
23. Imbard A, Benoist JF, Blom HJ. Neural tube defects, folic acid and methylation. Int J Environ Res Public Health. 2013;10:4352-43589. doi: 10.3390/ijerph10094352 PMID: 24048206
24. Guy J, Cheval H, Selfridge J, Bird A. The role of MeCP2 in the brain. Annu Rev Cell Dev Biol. 2011;27:631-652. doi: 10.1146/annurev-cellbio-092910-154121 PMID: 21721946
25. Numata S et al. DNA methylation signatures in development and aging of the human prefrontal cortex. Am J Hum Genet. 2012, 90:260-272.
26. Erratum in: Am J Hum Genet. 2012 Oct. 5;91:765. doi: 10.1016/j.ajhg.2011.12.020 PMID: 22305529
27. Muratore CR et al. Age-dependent decrease and alternative splicing of methionine synthase mRNA in human cerebral cortex and an accelerated decrease in autism. PloS One. 2013;8:e56927. doi: 10. 1371/journal.pone.0056927 PMID: 23437274
28. Ladd-Acosta C, Hansen KD, Briem E, Fallin MD, Kaufmann WE, Feinberg AP. Common DNA methylation alterations in multiple brain regions in autism. Mol Psychiatry. 2014;19:862-871. doi: 10.1038/mp. 2013.114 PMID: 23999529
29. James SJ, Shpyleva S, Melnyk S, Pavliv O, Pogribny IP. Elevated 5-hydroxymethylcytosine in the Engrailed-2 (EN-2) promoter is associated with increased gene expression and decreased MeCP2 binding in autism cerebellum. Transl Psychiatry. 2014;4:e460. doi: 10.1038/tp. 2014.87 PMID: 25290267
30. Rose S, Melnyk S, Pavliv O, Bai S, Nick TG, Frye RE. et al. Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl Psychiatry. 2012;2:e134. doi: 10.1038/tp. 2012.61 PMID: 22781167
31. Chauhan A, Audhya T, Chauhan V. Brain region-specific glutathione redox imbalance in autism. Neurochem Res. 2012;37:1681-1689. doi: 10.1007/s11064-012-0775-4 PMID: 22528835
32. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL. et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry. 2004;9:684-697. PMID: 15098003
33. Do KQ, Cabungcal JH, Frank A, Steullet P, Cuenod M. Redox dysregulation, neurodevelopmentand schizophrenia. Curr Opin Neurobiol. 2009;19:220-230. doi: 10.1016/j.conb.2009.05.001 PMID: 19481443
34. Steullet P, Cabungcal JH, Kulak A, Kraftsik R, Chen Y, Dalton TP. et al. Chronic Redox Dysregulation Affects the Ventral But Not Dorsal Hippocampus: Impairment of Parvalbumin Neurons, Gamma Oscillations and Related Behaviors. J Neurosci. 2010;30:2547-2558. doi: 10.1523/JNEUROSCI.3857-09. 2010 PMID: 20164340
35. Hannibal L, Axhemi A, Glushchenko AV, Moreira ES, Brasch NE, Jacobsen DW. Accurate assessment and identification of naturally occurring cellular cobalamins. Clin Chem Lab Med. 2008;46:1739-1746. doi: 10.1515/CCLM.2008.356 PMID: 18973458
36. Hodgson N, Trivedi M, Muratore C, Li S, Deth R. Soluble oligomers of amyloid-β cause changes in redox state, DNA methylation, and gene transcription by inhibiting EAAT3 mediated cysteine uptake. J Alzheimers Dis. 2013;36:197-209. doi: 10.3233/JAD-130101 PMID: 23579332
37. Waly MI, Kharbanda KK, Deth RC. Ethanol lowers glutathione in rat liver and brain and inhibits methionine synthase in a cobalamin-dependent manner. Alcohol Clin Exp Res. 2011;35:277-283. doi: 10. 1111/j.1530-0277.2010.01343.x PMID: 21121936
38. Yang Y, Dieter MZ, Chen Y, Shertzer HG, Nebert DW, Dalton TP. Initial characterization of the glutamate-cysteine ligase modifier subunitGclm (-/-) knockout mouse. Novel model system for a severely compromised oxidative stress response. J Biol Chem. 2002;277:49446-49452. PMID: 12384496
39. Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW. et al. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med. 1999;131:331-339. PMID: 10475885
40. Tallan HH, Moore S, Stein WH. L-cystathionine in human brain. J Biol Chem. 1958;230:707-716. PMID: 13525388
41. Sturman JA, Rassin DK, Gaull GE. Relation of three enzymes of transsulphuration to the concentration of cystathionine in various regions of monkey brain. J Neurochem. 1970;17:1117-1119. PMID: 4987664
42. Do KQ, Trabesinger AH, Kirsten-Krüger M, Lauer CJ, Dydak U, Hell D. et al. Schizophrenia: glutathione deficit in cerebrospinal fluid and frontal cortex in vivo. Eur J Neurosci. 2000;12:3721-3728. PMID: 11029642
43. das Neves Duarte JM, Kulak A, Gholam-Razaee MM, Cuenod M, Gruetter R, Do KQ. N-acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development. Biol Psychiatry. 2012;71:1006-1014. doi: 10.1016/j.biopsych.2011.07.035 PMID: 21945305
44. Spuch C, Navarro C. Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2). Recent Pat Endocr Metab Immune Drug Discov. 2010;4:190-205.
45. Moestrup SK et al. Megalin-mediated endocytosis of transcobalamin-vitamin-B12 complexes suggests a role of the receptor in vitamin-B12 homeostasis. Proc Natl Acad Sci USA. 1996;93:8612-8617. PMID: 8710919
46. Bose S, Kalra S, Yammani RR, Ahuja R, Seetharam B. Plasma membrane delivery, endocytosis and turnover of transcobalamin receptor in polarized human intestinal epithelial cells. J Physiol. 2007;581:457-466. PMID: 17347267
47. Fernandez-Roig S, Lai S-C, Murphy MM, Fernandez-Ballart J, Quadros EV. Vitamin B12 deficiency in the brain leads to DNAhypomethylation in the TCblR/CD320 knockout mouse. Nutr Metab. 2012;9:41.
48. Jensen LL, Andersen RK, Hager H, Madsen M. Lack of megalin expression in adult human terminal ileum suggests megalin-independent cubilin/amnionless activity during vitamin B12 absorption. Physiol Rep. 2014;2:e12086. doi: 10.14814/phy2.12086 PMID: 25052491
49. Pascale CL, Miller MC, Chiu C, Boylan M, Caralopoulos IN, Gonzalez L, et al. Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent. Fluids Barriers CNS. 2011;8:21. doi: 10.1186/2045-8118-8-21 PMID: 21740544
50. ∗2 allele and methionine synthase 2756 AA genotype with dementia severity of sporadic Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2004;75:1036-1038. PMID: 15201366
51. Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One 2010;5:e12244. doi: 10.1371/journal.pone.0012244 PMID: 20838622
52. Douaud G. Refsum H, de Jager CA, Jacoby R, Nichols TE, Smith SM, et al. Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci USA. 2013;110:9523-9528. doi: 10.1073/pnas.1301816110 PMID: 23690582
53. Kim J, Gherasim C, Banerjee R. Decyanation of vitamin B12 by a trafficking chaperone. Proc Natl Acad Sci USA. 2008 Sep. 23;105(38):14551-14554. doi: 10.1073/pnas.0805989105 PMID: 18779575
54. 12 trafficking protein. J Biol Chem. 2014;289:16487-16497. doi: 10.1074/jbc. M114. 567339 PMID: 24742678
55. Horvath S. DNAmethylation age of human tissues and cell types. Genome Biol. 2013;14:R115. PMID: 24138928
56. Zovkic IB, Guzman-Karlsson MC, Sweatt JD. Epigenetic regulation of memory formation and maintenance. Learn Mem. 2013;20:61-74. doi: 10.1101/lm.026575.112 PMID: 23322554
57. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr. 2004;80:1611-1617. PMID: 15585776
58. James SJ. Melnyk S, Jernigan S, Cleves MA, Halsted CH, Wong DH, et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet. 2006;141B:947-956. PMID: 16917939
59. Al-Gadani Y. El-Ansary A, Attas O, Al-Ayadhi L. Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. Clin Biochem. 2009;42:1032-1040. doi: 10.1016/j. clinbiochem.2009.03.011 PMID: 19306862
60. Paşca SP, Dronca E, Kaucsár T, Craciun EC, Endreffy E, Ferencz BK, et al. One Carbon Metabolism Disturbances and the C667T MTHFR Gene Polymorphism in Children with Autism Spectrum Disorders. J Cell Mol Med. 2009;13:4229-4238. doi: 10.1111/j.1582-4934.2008.00463.x PMID: 19267885
61. Melnyk S. Fuchs GJ, Schulz E, Lopez M, Kahler SG, Fussell JJ, et al. Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism. J Autism Dev Disord. 2012;42:367-377. doi: 10.1007/s10803-011-1260-7 PMID: 21519954
62. Frustaci A, Neri M, Cesario A, Adams JB, Domenici E, Dalla Bernardina B, et al. Oxidative stressrelated biomarkers in autism: systematic review and meta-analyses. Free Radic Biol Med. 2012;52:2128-2141. doi: 10.1016/j.freeradbiomed.2012.03.011 PMID: 22542447
63. Deth R, Muratore C, Benzecry J, Power-Charnitsky V-A, Waly M. How environmental and genetic factors combine to cause autism: A redox/methylation hypothesis. Neurotoxicology. 2008;29:190-201. PMID: 18031821
64. Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, et al. Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr Metab (Lond). 2011;8:34.
65. Al-Farsi YM, Waly MI, Deth RC, Al-Sharbati MM, Al-Shafaee M, Al-Farsi O, et al. Low folate and vitamin B12 nourishment is common in Omani children with newly diagnosed autism. Nutrition. 2013;29:537-541. doi: 10.1016/j.nut.2012.09.014 PMID: 23287069
66. Kemperman RF, Veurink M, vander Wal T, Knegtering H, Bruggeman R, Fokkema MR, et al. Low essential fatty acid and B-vitamin status in a subgroup of patients with schizophrenia and its response to dietary supplementation. Prostaglandins Leukot Essent Fatty Acids. 2006;74:75-85. PMID: 16384692
67. Kale A, Naphade N, Sapkale S, Kamaraju M, Pillai A, Joshi S, et al. Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism. Psychiatry Res 2010;175:47-53. doi: 10. 1016/j.psychres.2009.01.013 PMID: 19969375
68. Ssonko M, Ddungu H, Musisi S. Low serum vitamin B12 levels among psychiatric patients admitted in Butabika mental hospital in Uganda. BMC Res Notes. 2014;7:90. doi: 10.1186/1756-0500-7-90 PMID: 24533701
69. Haidemenos A, Kontis D, Gazi A, Kallai E, Allin M, Lucia B, et al. Plasma homocysteine, folate and B12 in chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:1289-1296. PMID: 17597277
70. Eren E, Yeʇin A, Yilmaz N, Herken H. Serum total homocysteine, folate and vitamin B12 levels and their correlation with antipsychotic drug doses in adult male patients with chronic schizophrenia. Clin Lab. 2010;56:513-518. PMID: 21141434
71. Saedisomeolia A, Djalali M, Moghadam AM, Ramezankhani O, Najmi L. Folate and vitamin B12 status in schizophrenic patients. J Res MedSci. 2011;16:S437-441. PMID: 22247731
72. Zhang Y, Hodgson N, Trivedi M, Deth R. Neuregulin-1 promotes glutathione-dependent neuronal cobalamin metabolism by stimulating cysteine uptake. Oxid Med and Cell Longevity. (In Press).
73. Kulak A, Cuenod M, Do KQ. Behavioral phenotyping of glutathione-deficientmice: relevance to schizophrenia and bipolar disorder. Behav Brain Res. 2012;226:563-570. doi: 10.1016/j.bbr.2011.10.020 PMID: 22033334
74. das Neves Duarte JM, Kulak A, Gholam-Razaee MM, Cuenod M, Gruetter R, Do KQ. N-acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development. Biol Psychiatry. 2012;71:1006-1014. doi: 10.1016/j.biopsych.2011.07.035 PMID: 21945305
75. Cabungcal JH, Steullet P, Morishita H, Kraftsik R, Cuenod M, Hensch TK, et al. Perineuronal nets protect fast-spiking interneurons against oxidative stress. Proc Natl Acad Sci USA. 2013;110:9130-9135. doi: 10.1073/pnas.1300454110 PMID: 23671099
76. Uhlhaas PJ, Pipa G, Lima B, Melloni L, Neuenschwander S, Nikolić D, et al. Neural synchrony in cortical networks: history, concept and current status. Front Integr Neurosci. 2009;3:17. doi: 10.3389/neuro.07.017.2009 PMID: 19668703
77. Andersson RH, Johnston A, Herman PA, Winzer-Serhan UH, Karavanova I, Vullhorst D et al. Neuregulin and dopamine modulation of hippocampal gamma oscillations is dependent on dopamine D4 receptors. Proc Natl Acad Sci USA. 2012;109:13118-13123. doi: 10.1073/pnas.1201011109 PMID: 22822214
78. Rapoport J, Chavez A, Greenstein D, Addington A, Gogtay N. Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited. J Am Acad Child Adolesc Psychiatry. 2009;48:10-8. doi: 10.1097/CHI.0b013e31818b1c63 PMID: 19218893
79. Ramaekers VT, Blau N, Sequeira JM, Nassogne MC, Quadros EV. Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits. Neuropediatrics. 2007;38:276-281. doi: 10.1055/s-2008-1065354 PMID: 18461502
80. Frye RE, Sequeira JM, Quadros EV, James SJ, Rossignol DA. Cerebral folate receptor autoantibodies in autism spectrum disorder. Mol Psychiatry. 2013;18:369-381. doi: 10.1038/mp. 2011.175 PMID: 22230883
81. Ooka S, Matsui T, Nishioka K, Kato T. Autoantibodies to low-density-lipoprotein-receptor-related protein 2 (LRP2) in systemic autoimmune diseases. Arthritis ResTher. 2003;5:R174-180. PMID: 12723989
82. Cohen SM, Nichols A, Wyatt R, Pollin W. The administration of methionine to chronic schizophrenic patients: a review of ten studies. Psychiatry. 1974;8:209-225.
83. Auta J, Smith RC, Dong E, Tueting P, Sershen H, Boules S, et al. DNA-methylation gene networkdysregulation in peripheral blood lymphocytes of schizophrenia patients. Schizophr Res. 2013;150:312-318. doi: 10.1016/j.schres.2013.07.030 PMID: 23938174
84. Muntjewerff JW, Kahn RS, Blom HJ, den Heijer M. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry. 2006;11:143-149. PMID: 16172608
85. Pu D, Shen Y, Wu J. Association between MTHFR gene polymorphisms and the risk of autism spectrum disorders: a meta-analysis. Autism Res. 2013;6:384-392. doi: 10.1002/aur.1300 PMID: 23653228
86. Peerbooms OL, van Os J, Drukker M, Kenis G, Hoogveld L; MTHFR in Psychiatry Group, et al. Metaanalysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability? Brain Behav Immun. 2011;25:1530-1543. doi: 10.1016/j.bbi.2010.12.006 PMID: 21185933
87. Mitchell ES, Conus N, Kaput J. B vitamin polymorphisms and behavior: evidence of associations with neurodevelopment, depression, schizophrenia, bipolar disorder and cognitive decline. Neurosci Biobehav Rev. 2014;47:307-320. doi: 10.1016/j.neubiorev. 2014.08.006 PMID: 25173634
88. Wu YL, Ding XX, Sun YH, Yang HY, Sun L. Methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and susceptibility to Parkinson's disease: a meta-analysis. J Neurol Sci. 2013;335:14-21. doi: 10.1016/j.jns.2013.09.006 PMID: 24064257
89. Beyer K, Lao JI, Latorre P, Riutort N, Matute B, Fernández-Figueras MT, et al. Methionine synthase polymorphism is a riskfactorfor Alzheimer disease. Neuroreport. 2003;14:1391-1394. PMID: 12876480
90. Solomon LR. Functional cobalamin (vitamin B12) deficiency: role of advanced age and disorders associated with increased oxidative stress. Eur J Clin Nutr. 2015;69:687-692. doi: 10.1038/ejcn. 2014.272 PMID: 25563739
91. Froese DS, Gravel RA. Genetic disorders of vitamin B (1) (2) metabolism: eight complementation groups-eight genes. Expert Rev Mol Med 2010;12:e37 doi: 10.1017/S1462399410001651 PMID: 21114891